BACKGROUND: Cystatin C (Cys C) is an established new marker of renal function in patients with various renal diseases and in kidney transplantation. However, few data are available for the early post-transplantation period. METHODS: Twenty-two patients who underwent renal transplantation (RTx) were evaluated for the kinetics of Cys C from day 0 to 14 in relation to creatinine and beta-2 microglobulin (B2MG). Blood samples were obtained immediately before and after transplantation and on a daily basis thereafter. Serum levels before transplantation (100%) were used to calculate reduction ratios. RESULTS: The decrease of the analytes differed considerably: immediately after RTx Cys C declined by 27.3% (P < 0.01). However, after 3 days, on average, all patients showed a significant increase in Cys C levels (15+/-2.5%; P < 0.01). B2MG levels fell quickly by 55.4 and 73.8% after days 1 and 7, respectively, and remained stable thereafter. In contrast, creatinine did not decrease immediately after RTx but fell slowly by 67.5% at the end of the study. Prior to rejection, all analytes showed a similar behaviour. Rejection treatment with high-dose methylprednisolone induced a significant increase in Cys C (+22.8+/-7.9%, P < 0.05), while in parallel, creatinine and B2MG decreased (-12.9+/-3.4 and -8.4+/-6.89%). CONCLUSIONS: Corticosteroid treatment for induction of immunosuppression or rejection therapy significantly induces Cys C, but decreases B2MG. Cys C and B2MG are not helpful in establishing the diagnosis of rejection earlier. Thus, our data indicate that Cys C and B2MG testing does not accurately reflect changes in the glomerular filtration rate early after transplantation.
BACKGROUND:Cystatin C (Cys C) is an established new marker of renal function in patients with various renal diseases and in kidney transplantation. However, few data are available for the early post-transplantation period. METHODS: Twenty-two patients who underwent renal transplantation (RTx) were evaluated for the kinetics of Cys C from day 0 to 14 in relation to creatinine and beta-2 microglobulin (B2MG). Blood samples were obtained immediately before and after transplantation and on a daily basis thereafter. Serum levels before transplantation (100%) were used to calculate reduction ratios. RESULTS: The decrease of the analytes differed considerably: immediately after RTxCys C declined by 27.3% (P < 0.01). However, after 3 days, on average, all patients showed a significant increase in Cys C levels (15+/-2.5%; P < 0.01). B2MG levels fell quickly by 55.4 and 73.8% after days 1 and 7, respectively, and remained stable thereafter. In contrast, creatinine did not decrease immediately after RTx but fell slowly by 67.5% at the end of the study. Prior to rejection, all analytes showed a similar behaviour. Rejection treatment with high-dose methylprednisolone induced a significant increase in Cys C (+22.8+/-7.9%, P < 0.05), while in parallel, creatinine and B2MG decreased (-12.9+/-3.4 and -8.4+/-6.89%). CONCLUSIONS: Corticosteroid treatment for induction of immunosuppression or rejection therapy significantly induces Cys C, but decreases B2MG. Cys C and B2MG are not helpful in establishing the diagnosis of rejection earlier. Thus, our data indicate that Cys C and B2MG testing does not accurately reflect changes in the glomerular filtration rate early after transplantation.
Authors: Aleksandra Kukla; Naim Issa; Scott Jackson; Richard Spong; Meredith C Foster; Arthur J Matas; Michael S Mauer; John H Eckfeldt; Hassan N Ibrahim Journal: Am J Nephrol Date: 2014-01-18 Impact factor: 3.754
Authors: Johan Mårtensson; Max Bell; Anders Oldner; Shengyuan Xu; Per Venge; Claes-Roland Martling Journal: Intensive Care Med Date: 2010-04-16 Impact factor: 17.440
Authors: Nori J L Smeets; Esther M M Teunissen; Kim van der Velden; Maurice J P van der Burgh; Demi E Linders; Elodie Teesselink; Dirk-Jan A R Moes; Camilla Tøndel; Rob Ter Heine; Arno van Heijst; Michiel F Schreuder; Saskia N de Wildt Journal: Pediatr Nephrol Date: 2022-08-02 Impact factor: 3.651
Authors: Emil den Bakker; Reinoud Gemke; Joanna A E van Wijk; Isabelle Hubeek; Birgit Stoffel-Wagner; Arend Bökenkamp Journal: Pediatr Nephrol Date: 2018-05-17 Impact factor: 3.714